+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

Myocardial Infarction (MI) Therapeutics Market 2026-2030 - Product Thumbnail Image

Myocardial Infarction (MI) Therapeutics Market 2026-2030

  • Report
  • January 2026
  • 290 Pages
  • Global
From
From
From
From
From
Insulin Sensitizers Market - Global Strategic Business Report - Product Thumbnail Image

Insulin Sensitizers Market - Global Strategic Business Report

  • Report
  • October 2026
  • 340 Pages
  • Global
From
From
From
From
Drug Device Combination Market Report 2026 - Product Thumbnail Image

Drug Device Combination Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Peptide Therapeutics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Peptide Therapeutics Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 192 Pages
  • Global
From
From
From
Advanced Drug Delivery Systems Market Report 2026 - Product Thumbnail Image

Advanced Drug Delivery Systems Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Tyrosine Kinase Inhibitors Market 2025-2029 - Product Thumbnail Image

Tyrosine Kinase Inhibitors Market 2025-2029

  • Report
  • December 2024
  • 195 Pages
  • Global
From
Loading Indicator